Comparative Pharmacology
Head-to-head clinical analysis: CHOLAC versus MAGNESIUM SULFATE ANHYDROUS POTASSIUM SULFATE SODIUM SULFATE.
Head-to-head clinical analysis: CHOLAC versus MAGNESIUM SULFATE ANHYDROUS POTASSIUM SULFATE SODIUM SULFATE.
CHOLAC vs MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lactulose is a synthetic disaccharide that is not absorbed in the small intestine. It is metabolized by colonic bacteria to short-chain fatty acids, primarily lactic acid and acetic acid, which lower the colonic pH. This acidification traps ammonia (NH3) as ammonium (NH4+) in the gut lumen, reducing serum ammonia levels. Additionally, the osmotic effect of lactulose draws water into the colon, producing a laxative effect.
Osmotic laxative that retains water in the bowel lumen via osmotic gradient, inducing diarrhea to cleanse the colon. Sodium sulfate, potassium sulfate, and magnesium sulfate are poorly absorbed, creating an osmotic effect. Additionally, magnesium may stimulate cholecystokinin release.
15-30 mL (10-20 g lactulose) orally once daily, titrated to produce 2-3 soft stools per day; maximum dose 60 mL/day. For hepatic encephalopathy: 30-45 mL (20-30 g) orally 3-4 times daily, titrated to 2-3 soft stools per day.
For bowel cleansing prior to colonoscopy: 3 packets (each packet contains 1.6 g magnesium sulfate anhydrous, 3.13 g potassium sulfate, and 1.5 g sodium sulfate) dissolved in water to make 16 ounces, followed by additional water: administer as a split-dose regimen (one 16-ounce solution the evening before and one 16-ounce solution on the day of the procedure).
None Documented
None Documented
0.5-1.5 hours for lactulose; active metabolites (e.g., acetic acid) have negligible systemic half-life due to rapid local metabolism.
Not applicable as a systemic half-life; the drug acts locally in the gastrointestinal tract. For absorbed sulfate, elimination half-life is approximately 6-8 hours in patients with normal renal function.
Primarily fecal (biliary excretion of unchanged drug and metabolites); minimal renal excretion (<5%).
Primarily renal excretion. Approximately 20% of sulfate is absorbed and excreted in urine; the remainder is eliminated fecally as unabsorbed drug. Potassium is mostly reabsorbed; excess is excreted renally.
Category C
Category C
Laxative
Laxative